References
- Statistics Korea, "2013 Senior citizen statistics", 2013 (http://kostat.go.kr).
- Health Insurance Review & Assessment Service, "Ministry for health, welfare and family affairs", 2010 (http://www.mw.go.kr).
- M. Shiba, J. H. Bower, D. M. Maraganore, S. K. McDonnell, B. J. Peterson, J. E. Ahlskog, D. J. Schaid, W. A. Rocca, "Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study", Mov. Disord., Vol. 15, No. 4, pp. 669-677, 2000. https://doi.org/10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5
- M. C. Rodriguez-Oroz, M. Jahanshahi, P. Krack, I. Litvan, R. Macias, E. Bezard, J. A. Obeso, "Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms", Lancet. Neurol., Vol. 8, No. 12, pp. 1128-1139, 2009. https://doi.org/10.1016/S1474-4422(09)70293-5
- L. M. Shulman, R. L. Taback, J. Bean, W. J. Weiner, "Comorbidity of the nonmotor symptoms of Parkinson's disease", Mov. Disord., Vol. 16, No. 3, pp. 507-510, 2001. https://doi.org/10.1002/mds.1099
- D. Aarsland, S. Pahlhagen, C. G. Ballard, U. Ehrt, P. Svenningsson, "Depression in Parkinson disease--epidemiology, mechanisms and management", Nat. Rev. Neurol., Vol. 26, No. 1, pp. 35-47, 2011.
- D. Aarsland, K. Andersen, J. P. Larsen, A. Lolk, P. Kragh-Sorensen, "Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study", Arch. Neurol., Vol. 60, No. 3, pp. 387-392, 2003. https://doi.org/10.1001/archneur.60.3.387
- M. Emre, "Dementia associated with Parkinson's disease", Lancet. Neurol., Vol. 2, No. 4, pp. 229-237, 2003. https://doi.org/10.1016/S1474-4422(03)00351-X
- C. H. Williams-Gray, T. Foltynie, C. E. Brayne, T. W. Robbins, R. A. Barker, "Evolution of cognitive dysfunction in an incident Parkinson's disease cohort", Brain, Vol. 130, No. 7, pp. 1787-1798, 2007. https://doi.org/10.1093/brain/awm111
- C. C. Janvin, J. P. Larsen, D. Aarsland, K. Hugdahl, "Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia", Mov. Disord., Vol. 21, No. 9, pp. 1343-1349, 2006. https://doi.org/10.1002/mds.20974
- J. N. Caviness, E. Driver-Dunckley, D. J. Connor, M. N. Sabbagh, J. G. Hentz, B. Noble, V. G. Evidente, H. A. Shill, C. H. Adler, "Defining mild cognitive impairment in Parkinson's disease", Mov. Disord., Vol. 22, No. 9, pp. 1272-1277, 2007. https://doi.org/10.1002/mds.21453
- M. W. Bondi, G. E. Smith, "Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology", J. Int. Neuropsychol. Soc., Vol. 20, No. 2, pp. 129-134, 2014. https://doi.org/10.1017/S1355617714000010
- K. Matsuura, M. Maeda, K. Yata, Y. Ichiba, T. Yamaguchi, K. Kanamaru, H. Tomimoto, "Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy", Eur. Neurol., Vol. 70, No. 1-2, pp. 70-77, 2013. https://doi.org/10.1159/000350291
- H. J. Ahn, J. Chin, A. Park, B. H. Lee, S. W. Seo, D. L. Na, "Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients", J. Korean Med. Sci., Vol. 25, No. 7, pp. 1071-1076, 2010. https://doi.org/10.3346/jkms.2010.25.7.1071
- D. A. Gold, "An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment", J. Clin. Exp. Neuropsychol., Vol. 34, No. 1, pp. 11-34, 2012. https://doi.org/10.1080/13803395.2011.614598
- C. Y. Wang, M. H. Hu, H. Y. Chen, R. H. Li, "Self-reported mobility and instrumental activities of daily living: test-retest reliability and criterion validity", J. Aging Phys. Act., Vol. 20, No. 2, pp. 186-197, 2012. https://doi.org/10.1123/japa.20.2.186
- L. Monaci, R. G. Morris, "Neuropsychological screening performance and the association with activities of daily living and instrumental activities of daily living in dementia: baseline and 18- to 24-month follow-up", Int. J. Geriatr. Psychiatry, Vol. 27, No. 2, pp. 197-204, 2012. https://doi.org/10.1002/gps.2709
- A. Gmitrowicz, A. Kucharska, "Developmental disorders in the fourth edition of the American classification: diagnostic and statistical manual of mental disorders (DSM IV-optional book)", Psychiatr. Pol., Vol. 28, No. 5, pp. 509-521, 1994.
- D. A. Regier, W. E. Narrow, M. B. First, T. Marshall, "The APA classification of mental disorders: future perspectives", Psychopathology, Vol. 35, No. 2-3, pp. 166-170, 2002. https://doi.org/10.1159/000065139
- K. R. Chaudhuri, D. G. Healy, A. H. Schapira, "Non-motor symptoms of Parkinson's disease: diagnosis and management", Lancet. Neurol., Vol. 5, No. 2, pp. 235-245, 2006. https://doi.org/10.1016/S1474-4422(06)70373-8
- A. W. Willis, M. Schootman, N. Kung, B. A. Evanoff, J. S. Perlmutter, B. A. Racette, "Predictors of survival in patients with Parkinson disease", Arch. Neurol., Vol. 69, No. 5, pp. 601-607, 2012. https://doi.org/10.1001/archneurol.2011.2370
- A. Athinoula, "Martinos Center for Biomedical Imaging, FreeSurfer", available from http://surfer.nmr.mgh.harvard.edu/.
- H. Braak, D. Sandmann-Keil, W. Gai, E. Braak, "Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry", Neurosci. Lett., Vol. 265, No. 1, pp. 67-69, 1999. https://doi.org/10.1016/S0304-3940(99)00208-6
- H. Braak, K. Del Tredici, W. P. Gai, E. Braak, "Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system", J. Chem. Neuroanat., Vol. 20, No. 3-4, pp. 245-252, 2000. https://doi.org/10.1016/S0891-0618(00)00101-0
- I. Liepelt-Scarfone, K. Gauss, W. Maetzler, K. Muller, C. Bormann, M. Fruhmann Berger, M. Timmers, J. Streffer, D. Berg, "Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study", Neuroepidemiology, Vol. 41, No. 3-4, pp. 174-182, 2013. https://doi.org/10.1159/000353560
- W. W. Beatty, K. A. Ryder, S. T. Gontkovsky, J. G. Scott, K. L. McSwan, K. J. Bharucha, "Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS", Arch. Clin. Neuropsychol., Vol. 18, No. 5, pp. 509-520, 2003.
- J. Bergman, V. Lerner, "Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease", Clin. Neuropharmacol., Vol. 25, No. 2, pp. 107-110, 2002. https://doi.org/10.1097/00002826-200203000-00009
- B. Pillon, B. Deweer, Y. Agid, B. Dubois, "Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases", Arch. Neurol., Vol. 50, No. 4, pp. 374-379, 1993. https://doi.org/10.1001/archneur.1993.00540040036010
- B. Pillon, B. Dubois, A. Ploska, Y. Agid, "Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy", Neurology, Vol. 41, No. 5, pp. 634-643, 1991. https://doi.org/10.1212/WNL.41.5.634
- L. Apostolova, G. Alves, K. S. Hwang, S. Babakchanian, K. S. Bronnick, J. P. Larsen, P. M. Thompson, Y. Y. Chou, O. B. Tysnes, H. K. Vefring, M. K. Beyer, "Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment", Neurobiol. Aging, Vol. 33, No. 9, pp. :2113-2124, 2012. https://doi.org/10.1016/j.neurobiolaging.2011.06.014
- T. O. Dalaker, R. Zivadinov, D. P. Ramasamy, et al., "Ventricular enlargement and mild cognitive impairment in early Parkinson's disease", Mov. Disord., Vol. 26, No. 2, pp. 297-301, 2011. https://doi.org/10.1002/mds.23443
Cited by
- 신경인지 검사를 위한 모션 센싱 시스템 vol.26, pp.2, 2017, https://doi.org/10.5369/jsst.2017.26.2.128